Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study

European urology oncology - Tập 4 - Trang 182-191 - 2021
Bas W.G. van Rhijn1,2,3,4, Anouk E. Hentschel2,5, Johannes Bründl3, Eva M. Compérat1,6, Virginia Hernández1,7, Otakar Čapoun1,8, H. Maxim Bruins1,9, Daniel Cohen1,10, Morgan Rouprêt1,11, Shahrokh F. Shariat1,12,13, A. Hugh Mostafid1,14, Richard Zigeuner1,15, Jose L. Dominguez-Escrig1,16, Maximilian Burger1,3, Viktor Soukup1,8, Paolo Gontero1,17, Joan Palou1,18, Theo H. van der Kwast19, Marko Babjuk1,12,13, Richard J. Sylvester1
1European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands
2Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
3Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany
4Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada
5Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands
6Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France
7Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
8Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic
9Urology, Radboud University Medical Center, Nijmegen, The Netherlands
10Urology, Royal Free London - NHS Foundation Trust, Royal Free Hospital, London, UK
11Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France
12Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic
13Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria
14Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK
15Urology, Medical University of Graz, Graz, Austria
16Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain
17Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy
18Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain
19Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada

Tài liệu tham khảo

Babjuk, 2019, European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)— 2019 update, Eur Urol, 76, 639, 10.1016/j.eururo.2019.08.016 Chang, 2016, Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline, J Urol, 196, 1021, 10.1016/j.juro.2016.06.049 Soukup, 2017, Eur Urol, 72, 801, 10.1016/j.eururo.2017.04.015 Sylvester, 2006, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials, Eur Urol, 49, 10.1016/j.eururo.2005.12.031 van Rhijn, 2009, Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy, Eur Urol, 56, 430, 10.1016/j.eururo.2009.06.028 Mostofi, 1973, 21 Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Eble, 2004 Harnden, 2007, A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change?, BJU Int, 99, 723, 10.1111/j.1464-410X.2006.06672.x Montironi, 2009, 2004 World Health Organization classification of the noninvasive urothelial neoplasms: inherent problems and clinical reflections, Eur Urol Suppl, 8, 453, 10.1016/j.eursup.2008.12.004 MacLennan, 2007, Histologic grading of noninvasive papillary urothelial neoplasms, Eur Urol, 51, 10.1016/j.eururo.2006.10.037 van Rhijn, 2015, Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications, Mod Pathol, 28, 695, 10.1038/modpathol.2014.154 van Rhijn, 2010, The pathologist’s mean grade is constant and individualizes the prognostic value of bladder cancer grading, Eur Urol, 57, 1052, 10.1016/j.eururo.2009.09.022 Hentschel, 2020, Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?, Urol Oncol, 38, 440, 10.1016/j.urolonc.2019.10.002 Chen, 2012, The 1973 WHO classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer, PLoS One, 7 Bosschieter, 2018, Reproducibility and prognostic performance of the 1973 and 2004 World Health Organization classifications for grade in non-muscle-invasive bladder cancer: a multicenter study in 328 bladder tumors, Clin Genitourin Cancer, 16, e985, 10.1016/j.clgc.2018.05.002 Burger, 2008, Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study, Eur Urol, 54, 835, 10.1016/j.eururo.2007.12.026 Gontero, 2014, Prognostic factors of’ high-grade’ Ta bladder cancers according to the WHO 2004 classification: are these equivalent to’ high-risk’ non-muscle-invasive bladder cancer?, Urol Int, 92, 136, 10.1159/000351961 Kamel, 2006, Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma, Eur J Surg Oncol, 32, 1139, 10.1016/j.ejso.2006.04.006 Pellucchi, 2015, Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?, BJU Int, 115, 267, 10.1111/bju.12666 Samaratunga, 2002, Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression, Urology, 60, 315, 10.1016/S0090-4295(02)01705-3 Oosterhuis, 2002, Newling DW, ten Kate F. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems, J Clin Pathol, 55, 900, 10.1136/jcp.55.12.900 Schned, 2007, Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems, J Urol, 178 Fransen van de Putte, 2015, Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder, Curr Opin Urol, 25, 427, 10.1097/MOU.0000000000000202 Otto, 2011, The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer, BJU Int, 107, 404, 10.1111/j.1464-410X.2010.09515.x van de Putte, 2018, The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer, BJU Int, 122, 978, 10.1111/bju.14238 Liedberg, 2012, The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading, Eur Urol, 62, 10.1016/j.eururo.2012.05.063